Else K J, Wakelin D
Department of Zoology, Nottingham University, University Park.
Parasitology. 1990 Jun;100 Pt 3:479-89. doi: 10.1017/s0031182000078793.
Strains of mice poorly (B10) or non-responsive (B10.BR) to a primary infection with Trichuris muris were protected against infection by vaccination with excretory/secretory (E/S) antigen in Complete Freund's Adjuvant (CFA). Protection in these mice was slow to be expressed compared to that in good responder strains. Vaccination boosted the IgG and IgG1 antibody responses to E/S antigen and altered the antigen recognition profiles, three high molecular weight antigens (80-85, 90-95, 105-110 kDa) being recognized by antibodies in sera from vaccinated but not control mice. B10.BR mice which had experienced a patent primary infection could not be protected against challenge infections by vaccination and this was correlated with depressed levels of IgG1, but not total IgG, to E/S antigen early post-challenge compared with vaccinated infected mice which had not seen an adult primary infection. There was also lack of recognition of the three high molecular weight antigens recognized by antibodies in sera from mice infected after vaccination. It is suggested that the rapid development of high levels of IgG1 antibodies, and the recognition of the three high molecular weight antigens, may reflect events that are important in protective immunity. Immunomodulation of host immunity by T. muris may therefore be achieved, at least in part, by the suppression of specific IgG1 levels, the production of an irrelevant IgG isotype and prevention of the recognition of critical antigens.
对初次感染鼠鞭虫反应较弱(B10)或无反应(B10.BR)的小鼠品系,通过在完全弗氏佐剂(CFA)中接种排泄/分泌(E/S)抗原进行疫苗接种后可免受感染。与反应良好的小鼠品系相比,这些小鼠的保护作用表达较慢。疫苗接种增强了对E/S抗原的IgG和IgG1抗体反应,并改变了抗原识别谱,接种疫苗的小鼠血清中的抗体识别三种高分子量抗原(80 - 85、90 - 95、105 - 110 kDa),而对照小鼠血清中的抗体则不识别。经历过显性初次感染的B10.BR小鼠不能通过疫苗接种免受攻击感染,这与攻击后早期与未经历过成虫初次感染的接种感染小鼠相比,对E/S抗原的IgG1水平降低有关,但总IgG水平未降低。接种疫苗后感染的小鼠血清中的抗体识别的三种高分子量抗原也未被识别。提示高水平IgG1抗体的快速产生以及对三种高分子量抗原的识别可能反映了在保护性免疫中起重要作用的事件。因此,鼠鞭虫对宿主免疫的免疫调节作用可能至少部分是通过抑制特异性IgG1水平、产生无关的IgG同种型以及阻止对关键抗原的识别来实现的。